1 / 39

Analysis of CAPD Patients in Australia and New Zealand (1992-1999)

This study examines the number of new patients, transplants, permanent transfers, deaths, and dialysis stock and flow of CAPD patients in Australia and New Zealand from 1992 to 1999. It also includes data on age, BMI, peritonitis-free survival, technique survival, relationship between weight gain and survival, KT/V related to dialysate volume, residual GFR, racial and diabetic origins, and peritoneal transport status.

lancasterm
Download Presentation

Analysis of CAPD Patients in Australia and New Zealand (1992-1999)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. New Patients Transplants Perm. Transfer Deaths No. Dialysing Stock and Flow of CAPD PatientsAustralia 1992 - 1999 Number of Patients 1403 Patients 92 93 94 95 96 97 98 99

  2. New Patients Transplants Perm. Transfer Deaths No. Dialysing Stock and Flow of CAPD PatientsNew Zealand 1992 - 1999 Number of Patients 621 Patients 92 93 94 95 96 97 98 99

  3. CAPD Patients (%) of all Dialysis

  4. Number (Per Million) CAPD Patients Australia 1992 - 1999

  5. Age of New CAPD Patients No. Pats. 5 16 35 69 114 132 228 96 1

  6. Age of Dialysing CAPD Patients No. Pats. 4 20 77 119 236 301 436 205 5

  7. CAPD Patients (%) of all Dialysis

  8. Number (Per Million) CAPD Patients New Zealand 1992 - 1999

  9. Age of New CAPD Patients No. Pats. 3 4 12 23 56 77 61 23 2

  10. Age of Dialysing CAPD Patients No. Pats. 0 13 33 64 127 178 160 42 4

  11.  Australia 1996 - 2000 BMI <20

  12.  New Zealand 1996 - 2000 BMI <20

  13.  Australia 1996 - 2000 BMI 20 - 24.9

  14.  New Zealand 1996 - 2000 BMI 20 - 24.9

  15.  Australia 1996 - 2000 BMI 25 - 29.9

  16.  New Zealand 1996 - 2000 BMI 25 - 29.9

  17.  Australia 1996 - 2000 BMI  30 - 34.9

  18.  New Zealand 1996 - 2000 BMI  30 - 34.9

  19. Peritonitis Free Survival Related to Race Australia 1992 - 1995 Caucasoid 35-54 yrs 55-64 yrs 35-54 yrs 55-64 yrs Aboriginal Maori/Pac Isl

  20. Peritonitis Free Survival Related to Race Australia 1996 - 1999 Caucasoid 55-64 yrs 35-54 yrs 55-64 yrs 35-54 yrs Aboriginal Maori/Pac Isl

  21. Peritonitis Free Survival Related to Race New Zealand 1992 - 1995 Caucasoid 55-64 yrs 35-54 yrs Maori/Pac Isl 35-54 yrs 55-64 yrs

  22. Peritonitis Free Survival Related to Race New Zealand 1996 - 1999 Caucasoid 35-54 yrs 55-64 yrs Maori/Pac Isl 35-54 yrs 55-64 yrs

  23. First CAPD Treatment to First Peritonitis Related to Age at Entry 1996 - 1999 % Survival Australia Age Group

  24. First CAPD Treatment to First Peritonitis Related to Age at Entry 1996 - 1999 % Survival New Zealand Age Group

  25. Patient Survival (PD Treatment at 90 days) Related to BMI 1991 - 1999 Australia BMI < < 20 vs 20-27.5 p=0.1505 < 20 vs >27.5 p=0.0294 20-27.5 vs >27.5 p=0.2183 Transplant Censored HD included

  26. Technique Survival (PD Treatment at 90 days) Effect of Weight Gain in First 12 Monthson Subsequent Survival 1991 - 1999 Australia BMI Change < > < 2.5 vs > 2.5 p=<0.01 Transplant and Death Censored

  27. Technique Survival (PD Treatment at 90 days) Effect of Weight Gain in First 12 Monthson Subsequent Survival 1991 - 1999 Australia BMI Change < > < 2.5 vs > 2.5 p=<0.01 Transplant Censored Death Failure

  28. Technique Survival (PD Treatment at 90 days) Effect of Weight Gain in First 12 Monthson Subsequent Survival 1991 - 1999 Australia BMI Change < > < 2.5 vs >2.5 p=0.0562 Transplant Censored HD Included

  29. KT/V Related to Volume of DialysateAustralia March 2000 Prescribed Achieved KT/V (Total) Dialysate Volume  1.8 > 1.8  56 L / week 96 (22.1%) 338 (77.9%)  70 L / week 145 (26.5%) 403 (73.5%) 241 741

  30. KT/V Related to Volume of DialysateNew Zealand March 2000 Prescribed Achieved KT/V (Total) Dialysate Volume  1.8 > 1.8  56 L / week 41 (21.5%) 150 (78.5%)  70 L / week 70 (28.1%) 179 (71.9%) 111 329

  31. Relationship of Residual GFR to KT/VMarch 2000 Residual GFR KT/V (Total) + S.E < 1 ml / min 1.99 ± 0.03 Aust  1 ml / min 2.31 ± 0.03 < 1 ml / min 1.97 ± 0.03 NZ  1 ml / min 2.35 ± 0.04

  32. Technique Survival PD (Censor Death and Transplantation) Racial Origin 1990 - 1995 Australia Cauc vs Aboriginal p = 0.0019

  33. Technique Survival PD (Censor Death and Transplantation) Racial Origin 1990 - 1995 New Zealand Cauc vs Pac Isl p = 0.0003 Maori vs Pac Isl p = 0.4020 Asian vs Pac Isl p = 0.1159

  34.  Technique Survival PD (Censor Death and Transplantation) Diabetic and Racial Origin 1990 - 1995 Australia

  35.  Technique Survival PD(Censor Death and Transplantation) Diabetic and Racial Origin 1990 - 1995 New Zealand

  36.  Technique Survival PD (Censor Death and Transplantation) Non Diabetic and Racial Origin 1990 - 1995 Australia

  37.  Technique Survival PD(Censor Death and Transplantation) Non Diabetic and Racial Origin 1990 - 1995 New Zealand

  38. PET D/P Creatinine at Four HoursNew PD Patients from 1-Oct-98

  39. Peritoneal Transport Status New Patients 1-Oct-1998 to 31-Mar-2000

More Related